BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32945619)

  • 1. A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple-negative breast cancer.
    Lin M; Jin Y; Jin J; Wang B; Hu X; Zhang J
    Cancer Med; 2020 Nov; 9(22):8540-8551. PubMed ID: 32945619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer.
    Pan WK; Ren SY; Zhu LX; Lin BC
    Am J Clin Oncol; 2024 Feb; 47(2):71-80. PubMed ID: 37871164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With
    Wang Z; Wang H; Sun X; Fang Y; Lu SS; Ding SN; Chen XS; Shen KW
    Front Oncol; 2020; 10():14. PubMed ID: 32038988
    [No Abstract]   [Full Text] [Related]  

  • 4. External validation of a published nomogram for prediction of brain metastasis in patients with extra-cerebral metastatic breast cancer and risk regression analysis.
    Genre L; Roché H; Varela L; Kanoun D; Ouali M; Filleron T; Dalenc F
    Eur J Cancer; 2017 Feb; 72():200-209. PubMed ID: 28042991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics.
    Sheng DL; Shen XG; Shi ZT; Chang C; Li JW
    Eur Radiol; 2022 Oct; 32(10):6575-6587. PubMed ID: 35759017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.
    Jin J; Gao Y; Zhang J; Wang L; Wang B; Cao J; Shao Z; Wang Z
    BMC Cancer; 2018 Apr; 18(1):446. PubMed ID: 29673325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer.
    Chen MS; Liu PC; Yi JZ; Xu L; He T; Wu H; Yang JQ; Lv Q
    Sci Rep; 2022 Aug; 12(1):14659. PubMed ID: 36038627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.
    Duan F; Song C; Ma Y; Jiang K; Xu F; Bi X; Huang J; Hong R; Huang Z; Lu Q; Yuan Z; Wang S; Xia W
    Drug Des Devel Ther; 2021; 15():3463-3473. PubMed ID: 34408400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.
    Graesslin O; Abdulkarim BS; Coutant C; Huguet F; Gabos Z; Hsu L; Marpeau O; Uzan S; Pusztai L; Strom EA; Hortobagyi GN; Rouzier R; Ibrahim NK
    J Clin Oncol; 2010 Apr; 28(12):2032-7. PubMed ID: 20308667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
    Gu Y; Wu G; Zou X; Huang P; Yi L
    Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
    Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
    World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China.
    Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B
    Breast; 2020 Oct; 53():172-180. PubMed ID: 32836201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A deep learning nomogram kit for predicting metastatic lymph nodes in rectal cancer.
    Ding L; Liu G; Zhang X; Liu S; Li S; Zhang Z; Guo Y; Lu Y
    Cancer Med; 2020 Dec; 9(23):8809-8820. PubMed ID: 32997900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program.
    Cabel L; Carton M; Pistilli B; Dalenc F; Vanlemnens L; Levy C; Jacot W; Debled M; Loeb A; Hennequin A; De la Motte Rouge T; Laborde L; Laurent C; Chamorey E; Parent D; Petit T; Mouret-Reynier MA; Campone M; Perrocheau G; Labreveux C; Bachelot T; Robain M; Lerebours F
    Breast; 2021 Apr; 56():18-25. PubMed ID: 33561617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a nomogram for predicting survival of breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
    Lyu MH; Ma YZ; Tian PQ; Guo HH; Wang C; Liu ZZ; Chen XC
    Chin Med J (Engl); 2021 Nov; 134(22):2692-2699. PubMed ID: 34743149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and external validation of a prediction model for brain metastases in patients with metastatic breast cancer.
    Wu Q; Sun MS; Liu YH; Ye JM; Xu L
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12333-12353. PubMed ID: 37432458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic and extrinsic flaws of the nomogram predicting bone-only metastasis in women with early breast cancer: An external validation study.
    Ouldamer L; Bendifallah S; Chas M; Boivin L; Bedouet L; Body G; Ballester M; Daraï E
    Eur J Cancer; 2016 Dec; 69():102-109. PubMed ID: 27821312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.